Didn't EVOKE fail at the primary endpoint of reducing dementia?

Sure, they hit a fucking surrogate, that's sometimes interesting for additional research.

But we have incredibly strong clinical evidece oral semaglutide did not significantly reduce clinical progression in patients with early symptomatic Alzheimer's disease.